Home
About
Contact
DISCLAIMER: This site is for informational purposes only. While we make every effort to keep it up to date, there is no guarantee that information is complete, accurate, comprehensive, or the same for all KP regions. The information on this site should not be interpreted or used as a substitute for professional medical care. Please consult your care provider for any personal health questions or before participating in clinical trials.
Search Results
Tip
Select Recruitment Status
Active, not yet recruiting
Active, currently enrolling
Active, enrolling only by invitation
Enrollment complete
Study completed
Enrollment on hold
Study terminated early
Select Study Type
INTERVENTIONAL
OBSERVATIONAL
Select Clinical Trial Type
Phase I
Phase II
Phase IIA
Phase IIB
Phase III
Phase IV
n/a
Select Clinical Area
Adolescent Medicine
Addiction Medicine
Allergy and Immunology
Anesthesiology
Cardiology
Complimentary and Alternative Med
Dermatology
Emergency Medicine
Endocrinology, Diabetes and Metabolism
Epidemiology
Family Medicine
Genetics
Geriatric Medicine
Gastroenterology
Hematology
Infectious Diseases
Internal Medicine
Nephrology
Lifestyle Medicine
Neurology/Neurological Disorders
Nuclear Medicine
Nursing
Obstetrics and Gynecology
Occupational Medicine
Oncology (Adult)
Oncology (Pediatrics)
Ophthalmology
Other
Otolaryngology/ENT
Pediatrics
Physical Medicine and Rehabilitation
Podiatric Medicine
Preventative Medicine
Psychiatry
Pulmonary Disease
Radiology
Rheumatology
Sports Medicine
Surgery (Colon and Rectal)
Surgery (General)
Surgery (Hand)
Surgery (Neurological)
Surgery (Orthopedic)
Surgery (Plastic)
Surgery (Thoracic)
Surgery (Urology)
Surgery (Vascular)
Urology
Select Regions
California - Northern
California - Southern
Colorado
Georgia
Hawaii
Mid-Atlantic
Northwest
Washington
Select Facility 1
Select Facility 2
Select Facility 3
Male
Female
Child (Birth - 17 yrs)
Adult (18 - 65 yrs)
Senior (66 and above)
Saved Studies
You currently don’t have any saved studies. To save a study, select the bookmark icon on the result listing.
Your search for
Hematology | All Regions
returned
37
studies.
Active, currently enrolling
Who can join
A Phase 3 Randomized Study of Loncastuximab Tesirine Combined With Rituximab Versus Immunochemotherapy in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) (LOTIS-5)
Keywords:
Loncastuximab Tesirine; Refractory Diffuse Large B-Cell Lymphoma; Relapsed…
Study Type:
INTERVENTIONAL |
Region:
Northwest
Enrollment complete
Who can join
International Phase 3 Trial in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ALL) Testing Imatinib in Combination With Two Different Cytotoxic Chemotherapy Backbones
Keywords:
Leukemia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Leukemia; Lymphoid;…
Study Type:
INTERVENTIONAL |
Region:
California - Northern
Active, currently enrolling
Who can join
A Phase 2 Study of Blinatumomab (NSC# 765986) in Combination With Nivolumab (NSC # 748726), a Checkpoint Inhibitor of PD-1, in B-ALL Patients Aged >/= 1 to < 31 Years Old With First Relapse
Keywords:
Leukemia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Leukemia; Lymphoid;…
Study Type:
INTERVENTIONAL |
Region:
California - Northern
Enrollment on hold
Who can join
Randomized Phase II Open Label Study of Lenalidomide R-CHOP (R2CHOP) vs. RCHOP (Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone) in Patients With Newly Diagnosed Diffuse Large B Cell Lymphoma
Keywords:
Oncology (Adult);Hematology;
Study Type:
INTERVENTIONAL |
Region:
California - Northern
Enrollment complete
Who can join
Risk-Stratified Randomized Phase III Testing of Blinatumomab (NSC#765986) in First Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL)
Keywords:
Leukemia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Leukemia; Lymphoid;…
Study Type:
INTERVENTIONAL |
Region:
California - Northern
Active, currently enrolling
Who can join
Pediatric Acute Leukemia (PedAL) Screening Trial - Developing New Therapies for Relapsed Leukemias
Keywords:
Oncology (Pediatrics); Oncology (Adult); Leukemia; Leukemia, Myeloid; Leukemia,…
Study Type:
INTERVENTIONAL |
Region:
California - Northern
Active, currently enrolling
Who can join
A Phase 3 Randomized Trial of Inotuzumab Ozogamicin (NSC#: 772518) for Newly Diagnosed High-Risk B-ALL; Risk-Adapted Post-Induction Therapy for High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and Disseminated B-LLy
Keywords:
Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Acute Disease,…
Study Type:
INTERVENTIONAL |
Region:
California - Northern
Enrollment complete
Who can join
A Phase III Study for Patients With Newly Diagnosed Acute Promyelocytic Leukemia (APL) Using Arsenic Trioxide and All-Trans Retinoic Acid
Keywords:
Leukemia; Promyelocytic; Neoplasms by Histologic Type; Neoplasms; Hematologic…
Study Type:
INTERVENTIONAL |
Region:
California - Northern
Enrollment complete
Who can join
A Phase I Study With an Expansion Cohort/Randomized Phase II Study of the Combinations of Ipilimumab, Nivolumab and Brentuximab Vedotin in Patients With Relapsed/Refractory Hodgkin Lymphoma
Keywords:
Oncology (Adult);Hematology; Neoplasms by Histologic…
Study Type:
INTERVENTIONAL |
Region:
California - Northern
Active, currently enrolling
Who can join
A Phase 3 Trial Investigating Blinatumomab (NSC# 765986) in Combination With Chemotherapy in Patients With Newly Diagnosed Standard Risk or Down Syndrome B-Lymphoblastic Leukemia (B-ALL) and the Treatment of Patients With Localized B-Lymphoblastic Lymphoma (B-LLy)
Keywords:
Lymphoma; Leukemia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Leukemia;…
Study Type:
INTERVENTIONAL |
Region:
California - Northern
1
2
3
4